Aged and BRCA -Mutated Stromal Cells Drive Epithelial Cell Transformation

Geyon L. Garcia & Lan Coffman et al.

Abstract

The fundamental steps in high-grade serous ovarian cancer (HGSOC) initiation are unclear, presenting critical barriers to the prevention and early detection of this deadly disease. Current models propose that fallopian tube epithelial (FTE) cells transform into serous tubal intraepithelial carcinoma (STIC) precursor lesions and subsequently into HGSOC. In this study, we report that an epigenetically altered mesenchymal stem cell niche, termed high-risk mesenchymal stromal/stem cell (hrMSC), exists prior to STIC lesion formation. hrMSCs are enriched in STIC stroma and contribute to a stromal “field effect” extending beyond the borders of the STIC lesion. hrMSCs promote DNA damage in FTE cells while also fostering FTE cell survival. hrMSCs induce malignant transformation of the FTE, resulting in metastatic cancer in vivo, indicating that hrMSCs promote cancer initiation. hrMSCs are significantly enriched in BRCA1/2 mutation carriers and increase with age. Combined, these findings indicate that hrMSCs can incite ovarian cancer initiation and have important implications for ovarian cancer detection and prevention.

Significance:

This work demonstrates a critical role of fallopian tube stromal cells in HGSOC initiation with implications for the pathophysiology of HGSOC formation and the development of prevention and early detection strategies critically needed in this disease. Additionally, the identification of stromal-mediated epithelial transformation has broad implications for understanding pan-cancer initiation.

See related commentary by Recouvreux and Orsulic, p. 1093

Funding
Honorable Tina Brozman Foundation (Tina's Wish) FundingRegulation of mitochondrial redox homeostasis and signaling in metastatic ovarian cancerProject 2: Combination PARPi-BETi to Overcome PARPi ResistanceCancer Research Career Enhancement and Related ActivitiesHigh-Throughput Computing for Genomics and Bioinformatics ResearchU.S. Department of Defense (DOD) Grant OC210139Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) FundingDefining the impact of stromal aging on ovarian cancer initiationRegulation of mitochondrial redox homeostasis and signaling in metastatic ovarian cancerProject 3: Investigating new treatment approaches based on DNA repair vulnerability in ARID1A mutated type I ovarian cancerHigh-Throughput Computing for Genomics and Bioinformatics ResearchU.S. Department of Defense Grant W81XWH-22-1-0852Defining the impact of stromal aging on ovarian cancer initiationProject 2: Combination PARPi-BETi to Overcome PARPi ResistanceDr. Miriam and Sheldon G. Adelson Medical Research Foundation FundingProject 3: Investigating new treatment approaches based on DNA repair vulnerability in ARID1A mutated type I ovarian cancerHonorable Tina Brozman Foundation Funding

National Cancer Institute (NCI)

R01CA242021

NCI NIH HHS

P50 CA272218

NCI NIH HHS

P30 CA047904

National Cancer Institute (NCI)

S10OD028483

National Cancer Institute (NCI)

AG077923

NCI NIH HHS

R01 CA242021

NCI NIH HHS

P50 CA228991

NIH HHS

S10 OD028483

NIA NIH HHS

U01 AG077923

National Cancer Institute (NCI)

P50CA272218-01A1

National Cancer Institute

P50CA272218-01A1

National Cancer Institute

AG077923

National Cancer Institute

R01CA242021

National Cancer Institute

P50 CA228991

National Cancer Institute

S10OD028483